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Australia antigen, Au(1), was first detected by Blumberg in 1964 in the serum of an 
Australian aborigine (1).  Work concerning the geographic distribution,  disease  asso- 
ciation,  genetics,  and physical and  chemical characteristics  of this  unusual  antigen 
has been reviewed (2).  In one of the early studies, specific anti-Au(1) antisera agglu- 
tinated particles  180-210  A in diameter which were isolated from the sera of patients 
with  viral  hepatitis  (3).  Furthermore,  antisera  to  the  Au(1)  antigen  coupled with 
fluorescein  isothiocyanate stMned intranuclear  granules in the liver cells  of patients 
with hepatitis (4).  This indicates that cells of the liver of patients with hepatitis con- 
tain an antigen in common with the serum particles.  All this strongly suggests that 
Au(1)  may be,  or may be part of,  a  hepatitis  virus.  The association of Au(1)  with 
acute and chronic hepatitis has already been well documented (5-15). 
One  of the  approaches  which  could shed  light  on  the  question  of whether 
Au(1) is a virus or not is to study the physical properties of purified Au(1) par- 
ticles to determine whether they are consistent with those known for viruses. It 
is also important to ascertain whether the particles contain nucleic acids. It is 
generally accepted that the hepatitis virus is small,  260 A  in diameter  or less, 
and that it survives at 56°C for 30 rain and freezing at  --10°C to --20°C for 
1 yr or longer. It is resistant to the action of enzymes, ether, and other chemical 
agents  (16),  and is present  in the blood of infected individuals  since hepatitis 
can be transferred by needle puncture. The Au(1) antigen is also found in high 
concentrations in the blood of individuals suffering from chronic hepatitis,  and 
has many of the properties of the postulated  hepatitis virus, as this report will 
show. 
Materials and Methods 
Source ofAu(1).--D. M. was a 21 year old male with Down's syndrome who had chemical 
and histological evidence of chronic hepatitis  and Au(1) in his serum when first seen by us in 
* This  work was supported  by U.S. Public Health Service grants  CA-06551, CA-08069, 
CA-06927 and  FR-05539 from the National  Institutes  of Health,  and  by an appropriation 
from  the  Commonwealth of Pennsylvania. 
1190 I.  MILLMAN,  L.  LOEB~ M.  BAYER,  AND  B.  BLUMBERG  1191 
1967.  These findings persisted. In early 1969 he developed acute granulocytic leukemia and 
was admitted to our Clinical Research Unit. During the course of his treatment he was given 
1.0 mCi of NaH~82po4 by intravenous injection and 24 hr later 250 ml of plasma was ob- 
tained by plasmapheresis. The patient died of leukemia 6 days later. 
Assay of Au(1).--Immunodiffusion  assays were  performed by  the  Ouchterlony method 
using the modifications of Blumberg and Riddell (17).  Immunoelectrophoresis was performed 
on 31/~ x 4a/~ inch photographic plates, using 1.1% agarose dissolved in sodium veronal buffer, 
pH 8.2,  ionic strength 0.038. 
Electron Microscopy.--Samples containing Au(1)  were  dialyzed  for 4-10 hr against dis- 
tilled water at 2-5°C.  For negative staining a  loopful of material was placed on a  carbon- 
formvar--eoated  copper grid to which an equal amount of staining solution was added. The excess 
fluid was immediately blotted with filter paper and the grid dried in the vacuum of the micro- 
scope. For negative staining 2% uranyl acetate (w/v) in water or 4% silicotungstate (w/v) 
in solution adjusted to pH 7 with 1 N NaOH was employed. Each technique gave equivalent 
results. The micrographs were taken with a modified Siemens Elmiskop I  (Siemens America, 
New York) electron microscope, using double condenser, 80 kv acceleration voltage, and 50 p 
objective apertures at magnifications of 40,000-80,000. 
Counting.--Radioactivity was determined by recording the Cerenkov radiation emitted 
by 32p in a  conventional liquid scintillation counter as described by Haberer  (18).  In pre- 
liminary experiments it was shown that the presence of 1 M sucrose, 4 M cesium chloride, and 
a variety of other inorganic salts did not diminish the amount of radioactivity detected. Since 
the radioactivity determination was carried out at 0°-2°C, without the addition of any scintil- 
lation solution, samples up to 20/A were completely recoverable for subsequent purification. 
Resistance of Au(1).--(a)  Enzymes: A serum fraction containing Au(1) was partially puri- 
fied by the method of Alter and Blumberg (19)  and standardized to a  concentration which 
produced a sharp precipitin line when assayed by the immunodiffusion technique. 25-ul por 
tions of this fraction were allowed to react with a series of enzymes under optimal conditions 
as described by the supplier (Worthington Biochemical Corporation, Freehold, N. J.)  of all 
but one of the enzymes. These enzymes included trypsin, wheat germ lipase, neuraminidase, 
alpha amylase, phospholipase C,  ribonuclease, and deoxyribonuclease. In addition, pronase 
(Calbiochem Corporation, Los Angeles, Calif.), was dissolved in distilled water in a concentra- 
tion of 2 mg/ml and 5/zl of this enzyme solution was allowed to react with 25/zl of Au(1) 
fraction. All enzyme reactions were carried out at 37°C for 1 hr. 
(b) Other agents: The effect of elevated temperatures was determined by incubating Au(1) 
in 0.05 M tris(hydroxymethyl)aminomethane (Tris) maieate buffer, pH 7.5,  at 56  °, 85  °, and 
100°C for 1 hr. A similar solution containing Au(1) was exposed to ether and chloroform for 1 
hr at room temperature. These solvents were removed by evaporation before immunoreac- 
tivity was determined. 
Chemical Methods.--Deoxyribonucleic acid was assayed by the method of Dische (20) and 
the fluorometric method of Kissane and Robins (21). Ribonucleic acid was determine  d by the 
method of Albaum and Umbreit (22) and protein by the method of Lowry et al. (23). 
RESULTS 
Preliminary results indicated that treatment  with the enzymes did not affect 
the immunoreactivity  or structure  of Au(1).  An isolation procedure  was  then 
devised  in which  enzymatic  digestion was  used to degrade  other constituents 
without  apparently  altering Au(1). 
Purification  of Au(1).--Step  1. Centrifugation:  100  ml  of  plasma  was  clari- 
fied  by  centrifugation  at 0°-2°C  for  1  hr  at  2000  g.  The  supernatant  was  re- 1192  PURIFICATION  AND  PROPERTIES  OF  AUSTRALIA  ANTIGEN 
centrifuged at 300,000 g for 18 hr. Au(1)  was detected only in the pellet; this 
was dispersed in 10 ml of 0.15 M NaC1. 
Step  2. Enzyme treatment: To  the  above  suspension  were  added  4  mg  of 
amylase, 0.4 mg  of lipase,  0.2  mg of neuraminidase  and 0.2  mmoles of Tris- 
HC1, pH 7.5.  The total volume (11.4  ml)  was incubated for  15  min at 37°C. 
Thereafter 0.6 ml of a solution containing 0.1 mmoles of cacl~, 4.0 mg of tryp- 
sin, and 0.1 mg of phospholipase C was added. The mixture then gelled. 2 ml of 
pronase  (10 mg/ml)  was added  and  the mixture incubated  for  1 hr.  The gel 
disappeared and an additional 2 ml of pronase was added. The incubation was 
continued  for an  additional  hour  and  then  the  mixture was cooled in  an  ice 
bath. 
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1.  Gel filtration.  5 ml of the enzyme-treated suspension was placed on a 650 x 
32 mm column of Sephadex  G-200 gel which  had previously been  equilibrated  with 
0.85% NaC1. Elution was with the same solution  and 5 ml fractions were collected. 
All recovered Au(1) material eluted with the void volume (peak I). 
Step 3. Gel filtration:  Portions (5 ml) of the enzyme-treated suspension were 
filtered through Sephadex G-200. The absorption profile is shown in Fig.  1. All 
fractions comprising the first peak (I), which contained Au(1), were combined. 
Fig. 2 shows an immunoelectrophoresis pattern of each of the separation stages. 
These  patterns  were  developed  by  adding  horse  anti-human  serum  to  the 
troughs. There is a decrease in the number and intensity of precipitin bands fol- 
lowing enzyme treatments and gel filtration. 
Step 4. Sucrose gradient centrifugation: The  combined  fractions  of  peak  I 
from step 3 were dialyzed against 0.01 ?a KC1 and sedimented through sucrose 
gradients. Fig. 3 shows an analysis of the gradient for 3~p incorporation and im- 
munoreactivity. Fractions  16-22 with major Cerenkov radioactivity and reac- 
tivity were then combined. 
Step 5. Centrifugation in  cesium chloride: Fractions  16-22 from step 4  were 
sedimented  in  cesium  chloride  gradients.  Fig.  4  shows  the  resultant  profile I.  MILLMAN~ L.  LOEB~ M.  BAYER, AND  B.  BLUMBERG  1193 
FIG. 2.  Immunoelectrophoretic patterns of fractions at different stages of purifica- 
tion.  Pattern  1  is starting plasma; pattern 2  is pellet after centrifugation (step  1); 
pattern 3  is enzyme-treated pellet suspension (step 2); pattern 4  is enzyme-treated 
pellet suspension passed through Sephadex G-200  (step 3). Troughs contained horse 
anti-human serum which does not contain anti-Au(1). 
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FIG. 3.  Sucrose gradient profile. Sucrose gradients were prepared and sampled by 
the  method  of  Martin and  Ames  (26).  Portions  (1.0  ml)  of peak I  in  step 3  were 
layered over 32.5  ml linear sucrose gradients ranging from  10 to 30% by volume, in 
0.01  ~t Tris maleate buffer pH 7.4. The gradients were centrifuged in a  Spinco SW 27 
rotor (Beckman Instruments, Inc., Fullerton, Calif.), at 57,000  g  for 20 hr at 2-5°C. 
Forty-drop fractions were  removed by puncturing  the bottom of  tile tubes.  Radio- 
activity was  determined by counting each  entire fraction for  100  rain; background 
was 20.4 cpm. Immunological reactivity of each fraction was determined as detailed 
in Materials and Methods. The line within the radioactivity peak represents the Au(1) 
positive range  according to  immunodiffusion. 1194  PURIFICATION  AND  PROPERTIES  OF  AUSTRALIA  ANTIGEN 
analyzed for 32p  content,  absorption  at  280  m/~, density,  and  reactivity with 
Au(1)  antiserum. Immunological reactivity was found in fractions 15-21 with 
greatest activity in fraction 16. The relative antigenicity of each fraction was 
determined by twofold dilution titration. That fraction which could produce a 
precipitin  line  at  the  highest  dilution  was considered  the  peak fraction.  The 
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Fie.  4.  The pooled immunoreactive fractions from the  sucrose  density gradients 
(Fig. 3) were dialyzed  against 0.0t ~  KC1 at 5°C for 18 hr and lyophilized.  The dried 
Au(1) fraction was then dissolved in a small volume of distilled water and mixed with 
saturated cesium chloride solution to produce a final density of 1.3. The resultant solu- 
tion (5.0 ml) was centrifuged in a Spinco SW 50 rotor at 222,000 g to equilibrium  (40 
hr).  10 drop fractions were collected  through the bottom of the tube. Bar represents 
Au(1)  activity measured by immunodiffusion  assay.  Solid  area within bar  indicates 
highest antigenic  activity. 
density of the peak fraction (fraction 16) is 1.21 and it falls within both the  280 
m/z and  (~erenkov peaks. The 280 m/~ peak seen in fraction 8  (Fig.  4)  is  not 
coincident with 32p or Au(1) activity. Its absorption profile is not characteristic 
of nucleic acid. Fractions  15-18 were combined and after dialysis against  0.01 
KC1 were used for subsequent studies. 
Analysis  for  Immunoreactivity.--Fig.  5  shows  an  immunoelectrophoretic 
analysis of the most purified fractions (15-18) derived from step 5. There is no 
reactivity with horse anti-human serum (pattern 2), indicating  the  absence of I.  MILLMAN,  L.  LOEB~ M.  BAYER,  AND  B.  BLUMBERG  1195 
serum proteins (pattern 3). In contrast, Au(1)  is seen in pattern  1 (arrow), in 
which  the purified material was reacted with human anti-Au(1).  A  precipitin 
band appears to be in the same position and has the same configuration as the 
band formed by unpurified Au(1)  (not shown).  The presence of Au(1)  in the 
most purified fractions (step 5) indicates resistance of the antigen to the enzyme 
treatments  and  to  gradient  manipulations.  The  absence  of detectable  serum 
components in purified fractions 15-18 was confirmed by immunodiffusion test. 
FIG.  5.  Immunoelectrophoretic patterns  of  purified  Au(1)  fractions  15-18  (see 
Fig.  4).  Pattern  1--Au(1) band (arrow)  developed  with anti-Au(1)  in trough below. 
Pattern 2--Au(1) reacted with horse anti-human serum placed in trough below. Pat- 
tern 3-- Whole plasma, containing Au(1), developed with horse anti-human serum in 
trough above. 
Extraction with Phenol or Ether.--The small amount of ~2p in the most puri- 
fied fraction prior to phenol extraction does not appear to be associated with 
nucleic acids of high molecular weight.  2 mg of calf thymus deoxyribonucleic 
acid as a carrier was added to the combined fractions 15-18 of step 5. After ex- 
traction with phenol by the procedure of Thomas and Abelson  (24)  and cen- 
trifugation of the aqueous phase in a cesium Chloride gradient, no nucleic acid 
as measured by 32p radioactivity was detected. It is possible that phenol did not 
dissociate nucleic  acid  from  the  protein.  In  a  parallel  isolation procedure  in 
which enzyme treatment was omitted, 70 % of the 32p radioactivity in the most 1196  PURIFICATION AND  PROPERTIES  OF  AUSTRALIA ANTIGEN 
purified fraction was extracted with ether. There was no nucleic acid detected 
chemically. The sensitivities of these methods  indicated  that  if nucleic  acids 
were present, the concentration of DNA was less than  1% and the concentra- 
tion of RNA less than 10 % of the total weight of protein. 
Effect of Other Agents.--Heat treatment at 85 ° and  100°C  destroyed detect- 
able immunological reactivity as revealed by immunodiffusion test. There was 
no apparent decrease in reactivity after heating Au(1)  solution to 56°C  for  1 
hr  and  the  reactivity was retained  in  the  unheated  control.  After ether  and 
chloroform treatments, two precipitin bands appeared where only one had been 
FIG.  6.  Negatively stained  particles  from purified  Au(1)  fractions  15-18  of  the 
cesium chloride gradient. Magnification  300,000. Bar indicates  1000 A. 
seen previously. This may indicate  that these treatments uncover other anti- 
genic groups.  One of the precipitin bands of the  ether-treated Au(1)  fraction 
appeared to be different from one of the two bands of chloroform-treated Au(1) 
fraction, since they crossed, i.e.,  did not form a line of identity. 
Electron Microscopy of Purified Au(1).--Fig.  6  is an electron micrograph of 
An(l) present in fractions 15-18 of the cesium chloride gradient. In some of the 
particles a central "core" was observed. Particles were found in all those cesium 
chloride fractions which produced a  precipitin band by immunodiffusion (Fig. 
4,  fractions 15-21).  The greatest concentration  of particles appeared to be in 
fraction 16. Heat (100°C), ether, or chloroform did not affect the appearance of 
Au(1)  as  seen  under  the  electron  microscope. However,  the  particles  disap- i.  MILLMAN, L.  LOEB, M.  BAYER, AND  B.  BLUMBERG  1197 
peared completely after treatment with Carnoy's solution (3 parts ethanol: 1 
part glacial acetic acid) followed by pronase digestion. 
DISCUSSION 
Australia  antigen was  apparently not  affected by enzyme digestion as de- 
termined by its  immunological characteristics  and  its  appearance under the 
electron microscope. The remarkable stability despite such treatment made it 
possible to remove most other human serum proteins as a preliminary step in 
the purification of Au(1). The absence of host-related material (i.e. serum pro- 
teins) was demonstrated by a sensitive criterion, namely, the lack of immuno- 
logical reactivity with horse anti-human serum in immunoelectrophoretic and 
immunodiffusion analysis. 
The buoyant density of purified Au(1)  was  1.21.  This value confirms the 
earlier result of Alter and Blumberg (19). This density is lower than that re- 
ported for most picorna- and parvoviruses (which are  comparable in size to 
Au(1) particles); these range between 1.32 and 1.4  (25). The lower density of 
purified Au(1) could result from the absence of nucleic acid and/or the presence 
of lipids. An external lipid coat has not been reported in viral agents of this size 
range. The presence of lipids in Australia antigen has previously been postu- 
lated on the basis of the staining reactions (19). Exposure to ether and chloro- 
form appears to uncover previously masked antigenic groups; when the treated 
Au(1)  was  tested  against  both  human  and  rabbit  anti-Au(1)  an  additional 
precipitin band was detected. 
The morphology of the particles isolated from the cesium chloride gradient, 
as revealed by the electron microscope, does not differ from that already re- 
ported by Bayer et al. (3). The particles are 180-210 A in diameter and in most 
cases spherical in shape. They have central cores and appear to be composed of 
subunits. A few elongated particles with the same diameter (3) have been ob- 
served in the present material. Considering the size of these particles they could 
be compared to the adeno- associated (AAV), parvo-, and picornavirus groups 
(25). In the most purified fractions there is no evidence for the presence of sig- 
nificant amounts of nucleic acid. Thus, it is possible that the 32p seen in the 
gradients containing Au(1) may have been associated with lipids or lipoproteins 
which were subsequently removed by the phenol extraction. 
The tentative hypothesis is that the bulk of material identified as Australia 
antigen may be an incomplete virus or virus capsid associated with viral hepa- 
titis. Studies are currently directed at isolating an infectious particle. 
SUMMARY 
Australia antigen [Au(1)], a particle associated with viral hepatitis,  was  iso- 
lated from the plasma  of a  patient with  chronic anicteric hepatitis  and leu- 
kemia who had received radioactive phosphorus. 1198  PURIFICATION AND  PROPERTIES  OF  AUSTRALIA ANTIGEN 
We have found that the immunoreactivity and appearance of Au(1)  in the 
electron  microscope were  not  altered  by  treatment  with  enzymes  including 
trypsin,  pronase,  lipase,  phospholipase  C,  ribonuclease,  deoxyribonuclease, 
amylase, and  neuraminidase.  In  contrast,  other serum constituents  were  de- 
graded by these  enzymes, Therefore,  treatment  of the patient's plasma with 
many enzymes was exploited as an initial step for the isolation of Au(1). Subse- 
quently, Au(1) was purified from the enzyme-treated 32P-labeled  plasma by gel 
filtration through  Sephadex G-200 and centrifugation through  sucrose and in 
cesium chloride gradients. There were no detectable human serum components 
in the purest fractions, as tested by immunoelectrophoresis and immunodiffu- 
sion. The density of the purified Au(1) was 1.21 in CsC1. The particle measured 
about 200 A in diameter, was predominantly spherical in shape and appeared to 
be composed of subunits.  Nucleic  acids  were  not  detected  by spectrophoto- 
metric,  radiochemical,  and  chemical  analyses.  Immunoreactivity of  purified 
Au(1) was destroyed by heating for 1 hr at 85°C but was stable at 56°C. Treat- 
ment with  Carnoy's solution  (3  parts ethanol: 1 part glacial acetic acid)  fol- 
lowed by pronase disrupted the particles as seen with the electron microscope. 
These findings, combined with other published information on Australia antigen 
and viral hepatitis, suggest that the bulk of Australia antigen in the blood of 
this patient is an incomplete virus or virus capsid. 
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